LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Zika Virus Tied to Potential Brain Damage in Newborns

By LabMedica International staff writers
Posted on 11 Jan 2016
Image: The female Aedes aegypti mosquito that transmits the Zika virus (Photo courtesy of James Gathany/CDC).
Image: The female Aedes aegypti mosquito that transmits the Zika virus (Photo courtesy of James Gathany/CDC).
Image: Non-purulent viral conjunctivitis or red eye with no pus, a symptom of Zika virus infection (Photo courtesy of Brazilian Ministry of Health).
Image: Non-purulent viral conjunctivitis or red eye with no pus, a symptom of Zika virus infection (Photo courtesy of Brazilian Ministry of Health).
The Brazilian authorities are investigating thousands of suspected cases of microcephaly in babies born to mothers infected with the mosquito-borne Zika virus, while they were pregnant.

Zika is a virus that is transmitted by the same Aedes mosquito that spreads dengue and chikungunya and infected people have clinical symptoms similar to those illnesses and it is possible that some suspected cases of dengue could be Zika.

Scientists at the Ministry of Health (Brasilia, Brazil) have been investigating potential links between Zika virus infection in pregnancy and fetal microcephaly since October 2015, when they reported an unusual surge in cases of microcephaly in newborns following a Zika virus outbreak in the northeastern states. Up to December 12, 2015, the Brazilian ministry had been notified of 2,401 suspected cases of microcephaly linked to Zika virus infection in pregnancy. Of these, 2,165 are under investigation, 134 have been confirmed and 102 have been discarded.

The most common symptoms of Zika infection are mild fever, rash, headache, joint pain and non-purulent conjunctivitis, which is red eye with no pus. One out of four people may not develop symptoms, but those who do, experience them from two to seven days. Severe disease requiring hospitalization is uncommon. A baby born with microcephaly has a smaller-than-normal head, caused by abnormal brain growth or because the brain stops growing. The brain fails to grow as the infant develops, and the condition often results in serious neurological and development problems and sometimes early death.

By December 22, 2015, a team at the Institute of Biomedical Sciences (ICB) at the University of Sao Paulo (Brazil) had already developed cultures for growing Zika in cells, a necessary first step for experiments and for obtaining diagnoses via DNA. Within a month, they expect to have a blood test for diagnosing Zika that is cheaper and easier than a DNA test. Angela Rocha, MD a pediatric infectologist, said, “It's a very personal decision, but at this moment of uncertainty, if families can put off their pregnancy plans, that's what we're recommending."

Related Links:

Brazilian Ministry of Health
University of São Paulo


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more